Iron oxide nanoparticles conjugated curcumin to promote high therapeutic efficacy of curcumin against hepatocellular carcinoma

摘要

Background: Curcumin's excellent conjugation capability with iron oxide nanoparticles plays a crucial role in enhancing both properties. Iron oxide, as a nanocarrier, will improve curcumin anticancer activity, while curcumin, as a capping agent, will minimize iron oxide nanoparticles toxicity and optimize their biomedical use.